Thompson Siegel & Walmsley’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,575
Closed -$705K 409
2025
Q1
$705K Sell
5,575
-2,425
-30% -$306K 0.01% 312
2024
Q4
$831K Buy
+8,000
New +$761K 0.01% 291
2015
Q2
Sell
-297,559
Closed -$4.68M 712
2015
Q1
$4.68M Sell
297,559
-493,295
-62% -$7.33M 0.08% 235
2014
Q4
$9.39M Buy
790,854
+60,661
+8% +$794K 0.18% 205
2014
Q3
$11.7M Buy
730,193
+333,736
+84% +$6.76M 0.23% 173
2014
Q2
$9.54M Sell
396,457
-68,001
-15% -$1.59M 0.19% 206
2014
Q1
$10.5M Buy
464,458
+24,899
+6% +$542K 0.24% 182
2013
Q4
$9.56M Buy
+439,559
New +$9.16M 0.22% 190

Other funds holding LRN

Thompson Siegel & Walmsley's LRN Position: Q2 2025 in Review

Thompson Siegel & Walmsley sold out of Stride (LRN) in Q2 2025, closing a stake of 5,575 shares — an estimated $705K sold.

Thompson Siegel & Walmsley first reported a position in LRN in Q4 2013 and held it in 8 quarters. The position peaked at $11.7M in Q3 2014. 535 funds tracked by Wall St. Rank hold LRN as of Q2 2025.

  • Thompson Siegel & Walmsley reported no remaining Stride position as of Q2 2025 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 5,575 Stride shares in Q2 2025, an estimated $705K.
  • Thompson Siegel & Walmsley first reported a position in Stride in Q4 2013 and held it in 8 quarters.
  • Thompson Siegel & Walmsley's Stride position peaked at $11.7M in Q3 2014.
  • 535 funds tracked by Wall St. Rank held Stride as of Q2 2025.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2025, filed 6 Aug 2025.